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The transfer of iron from 59Fe-labelled human spleen ferritin to human apotransferrin occurs in the absence 
of either educing or chelating agents. The reaction is first order with respect to ferritin and zero order to 
apotransferrin. The transfer is enhanced by low-Mr substances from human serum such as ascorbate, citrate, 
bicarbonate and lactate. A mixture of the four molecules at their normal physiological concentrations can 
increase the iron exchange to the same extent as that observed with an ultrafiltrate of serum. A pathway 
of intracellular i on mobilization isconsidered. 
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1. INTRODUCTION 
Iron plays an essential role in a large number of 
biological functions. In the serum and the ex- 
travascular fluids, it is transported by transferrin, 
a /?-globulin consisting of a single polypeptide 
chain of Mr -80000 [1,2] with two specific metal- 
binding sites. The iron-storage protein ferritin 
maintains iron in a soluble, non-toxic and bio- 
available form within cells. The structure of horse 
spleen apoferritin consists of 24 symmetrically 
related subunits forming a near-spherical hollow 
shell. The central cavity is occupied by iron 
deposited in small crystalline particles essentially 
as an inorganic ferric oxyhydroxide polymer with 
some phosphate [3]. 
The uptake of iron from serum transferrin by a 
number of cell types, both normal and trans- 
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formed, follows a similar pathway (review [4]). 
After binding to a specific receptor at the plasma 
membrane the transferrin-receptor complex is in- 
ternalized within an endosome and at some stage 
during the passage of the complex from the en- 
dosome to the compartment of uncoupling of 
receptor and ligand (CURL) the iron is released as 
a consequence of the energy-associated pumping 
of protons into the vesicle (and presumably of 
other factors such as complexation of Fe 3+ by 
biological chelators). The apotransferrin remains 
firmly bound to its receptor and is recycled back to 
the plasma membrane where it dissociates from the 
receptor at the neutral pH of the extracellular 
fluid. The iron released within the cell is rapidly in- 
corporated into cytosol ferritin and into mitochon- 
dria [5,6]. 
While we know much about the uptake of 
transferrin iron by cells, little is known about the 
mechanisms by which intracellular iron is mobilis- 
ed from ferritin. In normal human subjects some 
40 mg tissue iron is mobilized per day [7]. 800/0 of 
this is accounted for by the recycling of iron de- 
rived from the catabolism of effete erythrocytes by 
the macrophages of the reticuloendothelial system 
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to the erythroid bone marrow for hemoglobin syn- 
thesis. Although apotransferrin receptors have 
been found recently on rat macrophages [8], the 
presence of apotransferrin does not appear to be 
essential for the excretion of iron by these cells [9]. 
It thus appears that the inverse 'transferrin cycle' 
[10,11] would probably not be appropriate to ex- 
plain the mechanism of intracellular iron 
mobilization. 
We report here experiments designed to quantify 
the iron transfer from human spleen ferritin to 
human apotransferrin influenced by serum 
ultrafiltrate and by some low-Mr substances at 
their normal physiological concentrations in 
blood. 
2. MATERIALS AND METHODS 
Human apotransferrin was purchased from 
Behring Diagnostics (La Jolla, CA). 59Fe was sup- 
plied as ferrous ammonium sulfate (crystalline) by 
the Radiochemical Centre (Amersham, England). 
Human spleen ferritin was isolated and purified 
essentially by the methods of Granick [12] and 
Penders et al. [13] modified by Crichton et al. [14] 
and Wustefeld-Nelis [ 15]. The purity of the protein 
was controlled by polyacrylamide gel elec- 
trophoresis n 0.1 M Tris-borate buffer at pH 8.6 
[14]. Apoferritin was prepared by sequential 
dialysis of human spleen ferritin against 1 o70 (v/v) 
thioglycolic acid in 0.25 M sodium acetate buffer, 
pH 5.5 (4 times), 0.507o NH4HCO3 (3 times), 1 mM 
Mops buffer, pH 7.0 (2 times), 50 mM EDTA buf- 
fer, pH 6.2 (1 time), and 1 mM Mops buffer, pH 
7.0 (4 times). 
59Fe-labelled reconstituted ferritin was prepared 
by the method established in this laboratory in 
which the yield of iron incorporation i to apofer- 
ritin was optimized, l voi. acidic FeSO4 solution 
(pH 3.0) was added to 1 vol. apoferritin (6 mg/ml) 
buffered by 1 vol. of 0.5 M Hepes and 0.5 M Mes, 
pH 7.0. The molar ratio Fe/apoferritin was main- 
tained between 200 and 800. After incubation 
overnight, the reconstituted ferritin was filtered 
and dialysed against 1 mM Mops buffer, pH 7.0 (2 
times), prior to determination of both iron and 
protein concentration. 
An ultrafiltrate of serum (or plasma) was 
prepared by ultrafiltration of the serum (or 
plasma) through a Diaflo PM-10 filter (Amicon, 
Oosterhout, Netherlands) with a cut-off of Mr 
10000 in an ultrafiltration cell. 
Serum ultrafiltrate, chelate, ascorbic a id and 
other solutions were adjusted to pH 7.5 before ad- 
dition to each reaction. All reactions were carried 
out in 0.05 M KC1/0.05 M Hepes, pH 7.5, and in- 
cubation performed at room temperature. At 
desired time intervals, 0.1 ml aliquots were taken 
for counting, and 1 ml aliquots were passed 
through a 1.5 x 6.0 cm column of Bio-Rad AGI- 
X4 anion-exchange r sin (Bio-Rad, Richmond, 
CA). The column was previously equilibrated with 
0.05 M KC1/0.05 M Hepes at pH 7.5; elution was 
carried out with the same buffer. About 7 ml 
eluate was collected and used for scintillation 
counting. Control experiments showed that 
transferrin was eluted exclusively with 0.05 M 
KC1/0.05 M Hepes buffer. Ferritin was then eluted 
from the column with 12 ml buffer containing 
0.5 M KC1. 
3. RESULTS 
3.1. [59Fe]Ferritin 
By using the optimalised conditions described 
previously, 59Fe was incorporated into human 
spleen apoferritin. About 70°70 of the initial 
radioactivity was detected in the 59Fe-reconstituted 
ferritin. The product of reconstitution was ana- 
lysed as described by Bryce and Crichton [16]. It 
was similar to native ferritin according to elec- 
trophoresis. Duplicate polyacrylamide gels were 
stained respectively for iron and protein. All of the 
protein migrated with the iron. 
3.2. Separation of ferritin and transferrin 
The mixture of the two proteins was rapidly 
separated by ion-exchange chromatography using 
Bio-Rad AGI-X4 resin. Fig.lA illustrates the 
separation of [SgFe]ferritin from apotransferrin 
immediately after mixing the two proteins. After 
20h of incubation, as shown in fig.lB, the 
apotransferrin had bound 59Fe. 
3.3. Iron transfer in the absence of reducing and 
chelating agent 
The exchange of iron from 59Fe-reconstituted 
ferritin to apotransferrin 0.05 M KCI/0.05 M 
Hepes buffer, pH 7.5, at 20°C as a function of fer- 
ritin concentration is shown in fig.2. For ferritin 
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Fig.l. Elution profiles of a mixture containing 0.2 mg apotransferrin and 0.2 mg [59Fe]ferritin. (A) Chromatography 
was carried out immediately after mixing the two proteins; (B) chromatography was carried out 20 h after mixing the 
two proteins: (e) protein concentration (mg/ml); (©) radioactivity (cpm × 103); Tf, transferrin; F, ferritin. 
labelled with an average of  800 iron atoms per pro- 
tein, the reaction followed first-order kinetics. 
When ferritin was incubated with varying amounts 
o f  apotransferrin, iron was taken up at a rate 
which appears to be independent of  transferrin 
concentration (table 1). 
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Fig.2. Iron transfer from [SgFe]ferritin to apotransferrin 
(400/zg/ml) after 21.5 h as a function of ferritin 
concentration. 
3.4. Effect of  serum ultrafiltrate on iron transfer 
When 50% (v/v) of  the rat or human serum 
ultrafiltrate was incubated with [59Fe]ferritin and 
apotransferrin, the rate of  iron uptake was 
significantly enhanced (fig.3). After 100 h incuba- 
tion, about 80 and 60% respectively more iron was 
transferred from ferritin to apotransferrin than the 
iron transferred in the absence of  any mediating 
agents. 
Table I 
Effect of apotransferrin concentration on iron transfer 
from [~gFe]ferritin to apotransferrin 
[Ferritin] ~g/ml): 45 45 90 90 
[Apotransferrin] (gg/ml): 200 400 200 400 
10 ~ ×,ug Fe 6 h 21.8 24.7 44.5 44.1 
transferred to 27 h 51.0 57.2 108.8 108.2 
apotransferrin 50 h 80.1 83.3 154.2 145.2 
78 h 98.6 100.6 186.8 187.5 
120 h 117.4 120.3 215.3 220.0 
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Fig.3. Iron transfer from reconstituted human spleen 
ferritin (90#g/ml, 800 Fe/molecule) to human 
apotransferrin (400 #g/ml) in the presence of 50070 (v/v) 
(e) human serum ultrafiltrate, (,.) rat serum 
ultrafiltrate; (x) mixture of bicarbonate, ascorbate, 
citrate and lactate; (o) in the absence of any mediators. 
3.5. Influence of low-Mr serum components on 
iron transfer 
In order to determine the biochemical nature of 
the factors in serum ultrafiltrate responsible for 
the activation of iron transfer, we studied the in- 
fluence of some substances present in human 
blood. Fig.4 illustrates the effects of ascorbate, 
citrate, lactate and bicarbonate which all enhance 
the rate of iron transfer from ferritin to 
apotransferrin i the range of their physiological 
concentration. 
The action of ascorbate may be accounted for by 
reduction of iron in the ferritin to Fe z+ which can 
be released from the protein and be bound to the 
apotransferrin molecule. The citrate molecule may 
be able to penetrate into the ferritin core and form 
an Fe3+-citrate complex. Apotransferrin could 
then take up iron from this complex. Carbonate 
has been shown to play a critical role in the iron- 
binding function of transferrin [18,19]. The car- 
bonate anion is exchangeable with bicarbonate free 
in solution. Transferrin does not bind iron in the 
absence of carbonate or a synergistic anion. As our 
incubation medium was always in equilibrium with 
the atmospheric COz, there was an almost constant 
bicarbonate concentration that was necessary for 
the formation of the ternary Fe-transferrin- 
carbonate complex. When the incubation medium 
contained an increasing amount of bicarbonate or 
lactate, the iron uptake by apotransferrin was 
slightly enhanced (fig.4C,D). 
To study the effect of the ensemble of the reduc- 
tor, chelate and synergistic anions, we have 
prepared a solution containing 0.07 mM ascor- 
bate, 0.161 mM citrate, 24.8 mM bicarbonate and 
1.3 mM lactate in 0.05 M KCI/0.05 M Hepes, pH 
7.5. 50070 (v/v) of the mixture was incubated with 
[59Fe]ferritin and apotransferrin as previously 
described for serum ultrafiltrate. The result 
(fig.3,X) indicated that the combination of these 
four molecules was comparable to human serum 
ultrafiltrate in the ability to increase the rate of 
iron transfer from ferritin to apotransferrin. 
4. DISCUSSION 
The present experiments how that iron ex- 
change from reconstituted ferritin to apotransfer- 
rin takes place in the absence of any reducing and 
chelating agent. No additional bicarbonate and 
other synergistic anions are necessary for the reac- 
tion. The atmospheric COE that is in equilibrium 
with the incubation medium provides enough 
bicarbonate anions that are essential for the iron 
binding capacity of the transferrin [20]. 
When the incubation medium contains serum 
ultrafiltrate the rate of iron transfer to  
apotransferrin was significantly enhanced. This in- 
crease is due to the presence of low-Mr substances 
in the human blood. These are: the reducer ascor- 
bate, the iron chelate citrate, the bicarbonate and 
the synergistic anion lactate. The combination of 
the four agents at their normal physiological con- 
centration in human blood is able to play the same 
role as the human serum ultrafiltrate in the ability 
to enhance the rate of iron uptake by transferrin. 
Ferritin is localized within the cell and transfer° 
rin in the circulation. At the cellular level, there is 
no evidence that these two proteins come into con- 
tact. The reaction of iron exchange between them 
in vitro seems to have little physiological meaning. 
The only possibility that this reaction could take 
place in vivo would be iron release from serum fer- 
ritin to transferrin. Saito et al. [9] have observed 
release of iron in a ferritin-like form by cultured 
rat macrophage after ingestion of 59Fe-labelled 
erythrocytes. They have also found that much of 
the initial labelled iron was bound to apotransfer- 
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Fig.4. Influence of some low-Mr substances on the iron transfer from 59Fe-reconstituted ferritin (90#g/ml, 
800 Fe/molecule) to apotransferrin (400 #g/ml) for different incubation times. (A) 10 h with ascorbate, (B) 24 h with 
citrate, (C) 23 h with lactate, (D) 20 h with bicarbonate. ( ) Respective physiological concentrations of each 
substance in human blood plasma [17]. 
rin in the incubation medium. The effect of serum 
ultrafiltrate on iron transfer suggests that the 
secreted ferritin and apotransferrin that come into 
contact in the blood would be able to exchange 
their iron easily. 
Consequently, we might consider the possibility 
of a pathway for mobilization of intracellular i on. 
When iron is excess in the cell, the biosynthesis of 
ferritin will be induced and iron will be released by 
secretion of ferritin to the circulatory system. In 
the blood, the iron of the secreted ferritin could be 
taken up by the apotransferrin and then 
transported elsewhere. Such a possible mechanism 
is under further investigation. 
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